Category: Diagnostic Technologies

Diagnostic Technologies

FDA Grants Breakthrough Device Designation for Hemoglobin Variant Test

The test uses miniaturized electrophoresis technology designed to enable decentralized access to quantitative hemoglobin data.

Diagnostic Technologies

Simplifying Coagulation Testing for Low-Volume Labs with the Sysmex CA-600 Series

The compact, fully automated hemostasis analyzers are designed for routine testing environments and as a reliable backup instrument in larger labs.

Diagnostic Technologies

What Clinical Lab Leaders Predict for 2026

AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.

Anatomic Pathology

AI-Assisted Digital Parasitology Workflow Shows Strong Agreement with Traditional Microscopy

Peer-reviewed study found 98% concordance between Techcyte's digital workflow and brightfield microscopy in routine clinical laboratory testing.

Digital Pathology

Valar Labs Partners with PathNet Lab to Expand AI Bladder Cancer Diagnostics

The collaboration will provide urologists and oncologists nationwide access to AI-powered tools for non-muscle invasive bladder cancer management.

Clinical Chemistry

Ozelle Unveils AI-Powered Complete Blood Morphology Solution

The all-in-one diagnostic platform combines hematology, biochemistry, and immunoassay testing in a single run.

Flow Cytometry

BD Partners to Advance Immunotherapy Research Through Flow Cytometry

The company's cell analyzer will enable the investigation of 30-plus cellular characteristics to capture key biological insights and support a planned 1,000-person immune profiling study.

Hematology & Serology

Using Rapid Blood Testing During Surgery to Limit Unnecessary Transfusions

Fast, patient-specific blood test results during surgery can help clinicians decide when transfusions are truly needed.

Immunoassay

DPYD Genotyping Assay Receives FDA Breakthrough Device Designation

The qPCR-based test detects variants that increase risk of severe fluoropyrimidine chemotherapy toxicity.

Mass Spectrometry

New Blood Test Signature Could Improve Type 2 Diabetes Risk Prediction

A 44-metabolite blood test signature identified by Mass General Brigham and Einstein researchers improved type 2 diabetes risk prediction in a study of over 23,000 participants, according to Nature Medicine.

Microbiology

Primerdesign Launches Magnetic Bead Extraction Kit for DNA and RNA

The exsig Mag RapidBead Pro kit features a four-step workflow that reduces extraction time to under 20 minutes.

Molecular Diagnostics

New Method Shows Superior Sensitivity in Liquid Biopsy Testing

Bridge Capture, a targeted NGS method, showed higher sensitivity for detecting rare ctDNA variants than two leading liquid biopsy assays, according to research in The Journal of Molecular Diagnostics.

Point-of-Care

Roche Receives FDA Clearance for Point-of-Care Bordetella Test

The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.

Urinalysis & Toxicology

ADLM Updates Emergency Department Drug Testing Guidance

New recommendations address evolving drug landscape and advancing testing technologies since original 2003 guidance.